19
Pharmacyclics, based in U.S.A, is a pharmaceutical company.
One of their notable products is IBRUTINIB, with a corresponding application number 210563 and regulatory information .
proudly manufactured in the
approval since 2018-02-16
Pharmacyclics's IMBRUVICA TABLET;ORAL, medication with 560MG of IBRUTINIB.
18
Pharmacyclics, based in U.S.A, is a pharmaceutical company.
One of their notable products is IBRUTINIB, with a corresponding application number 210563 and regulatory information .
proudly manufactured in the
approval since 2018-02-16
Pharmacyclics's IMBRUVICA TABLET;ORAL, medication with 280MG of IBRUTINIB.
17
Pharmacyclics, based in U.S.A, is a pharmaceutical company.
One of their notable products is IBRUTINIB, with a corresponding application number 210563 and regulatory information .
proudly manufactured in the
approval since 2018-02-16
Pharmacyclics's IMBRUVICA TABLET;ORAL, medication with 420MG of IBRUTINIB.
16
Pharmacyclics, based in U.S.A, is a pharmaceutical company.
One of their notable products is IBRUTINIB, with a corresponding application number 210563 and regulatory information .
proudly manufactured in the
approval since 2018-02-16
Pharmacyclics's IMBRUVICA TABLET;ORAL, medication with 140MG of IBRUTINIB.